Complete regression of breast tumour with a single dose of docetaxel-entrapped core-cross-linked polymeric micelles.

@article{Hu2015CompleteRO,
  title={Complete regression of breast tumour with a single dose of docetaxel-entrapped core-cross-linked polymeric micelles.},
  author={Qizhi Hu and Cristianne J.F. Rijcken and Ruchi Bansal and Wim E. Hennink and Gert Storm and Jai Prakash},
  journal={Biomaterials},
  year={2015},
  volume={53},
  pages={
          370-8
        }
}
Oligo(Lactic Acid)8-Docetaxel Prodrug-Loaded PEG-b-PLA Micelles for Prostate Cancer
TLDR
O(LA)8-DTX micelles proved to be as efficacious but less toxic than Taxotere® in a preclinical mouse model of prostate cancer and enhanced drug-carrier compatibility.
Development of PSMA-targeted and core-crosslinked glycol chitosan micelles for docetaxel delivery in prostate cancer therapy.
Clinical application of polymeric micelles for the treatment of cancer
TLDR
Both non-covalent and chemical strategies have been used to improve the stability in the circulation and to retain the loaded drug in the PM to result in the accumulation of the drug at the target site to a greater extent than in healthy tissues and will, in principle, lead to improved therapeutic outcome.
Trastuzumab targeted micellar delivery of docetaxel using dendron-polymer conjugates.
TLDR
Cytotoxicity experiments on MCF-7 and SK-OV-3 cell lines displayed improved toxicity levels for targeted micelles in comparison with the non-targeted counterparts, whereas pulse-chase experiments indicated effectiveness of micellar formulations and the presence of targeting groups.
Improved Bioavailability and Antitumor Effect of Docetaxel by TPGS Modified Proniosomes: In Vitro and In Vivo Evaluations
TLDR
The results demonstrated DTX-TPGS-PN is promising in enhancing the bioavailability and efficiency of poorly water-soluble drug DTX, and the potential of proniosomes as stable precursors for oral drug delivery.
Folic acid functionalized long-circulating co-encapsulated docetaxel and curcumin solid lipid nanoparticles: In vitro evaluation, pharmacokinetic and biodistribution in rats
TLDR
The F-DC-SLN improved the efficacy and pharmacokinetic profile of DTX exhibiting enhanced potential in optimizing breast cancer therapy and may avoid to toxicity these vital organs.
A phase I dose-escalation and pharmacokinetic study of a micellar nanoparticle with entrapped docetaxel (CPC634) in patients with advanced solid tumours.
Nanoparticles Loaded with Docetaxel and Resveratrol as an Advanced Tool for Cancer Therapy
TLDR
The co-delivery of Dtx and Res in one actively targeted delivery system providing the simultaneous release of both drugs in cancer cells has a chance to fulfil the requirements of effective anticancer therapy and reduce limitations in therapy caused by multidrug resistance (MDR).
...
...

References

SHOWING 1-10 OF 50 REFERENCES
Docetaxel-Loaded Pluronic P123 Polymeric Micelles: in Vitro and in Vivo Evaluation
TLDR
Novel docetaxel (DTX) -loaded Tween 80-free Pluronic P123 (P123) micelles with improved therapeutic effect and remarkable antitumor activity and reduced toxicity on B16 tumor in vivo are developed.
In vivo delivery of silica nanorattle encapsulated docetaxel for liver cancer therapy with low toxicity and high efficacy.
TLDR
Results prove that the SN-PEG-Dtxl has low toxicity and high therapy efficacy, which provides convincing evidence for the silica nanorattle as a promising candidate for a drug delivery system.
NC-6301, a polymeric micelle rationally optimized for effective release of docetaxel, is potent but is less toxic than native docetaxel in vivo
TLDR
NC-6301 with an optimized release rate improved the potency of DTX while reducing its toxicity, and significantly inhibited growth of OCUM-2MLN human scirrhous gastric carcinoma in an orthotopic mouse model.
Nano-sized assemblies of a PEG-docetaxel conjugate as a formulation strategy for docetaxel.
TLDR
The anti-cancer activity of the drug in the PEG-DTX micelle formulation was demonstrated to be retained in three human cancer cell lines and the maximum tolerated dose of this DTX formulation was also 2.5-fold higher than that for Taxotere(R) in healthy mice.
Docetaxel conjugate nanoparticles that target α-smooth muscle actin-expressing stromal cells suppress breast cancer metastasis.
TLDR
In 4T1 and MDA-MB-231 orthotopic breast tumor models, Cellax therapy reduced α-smooth muscle actin (α-SMA) content and lung nodules were reduced by 7- to 24-fold by Cellax treatment, whereas native docetaxel and nab-paclitaxel treatments were ineffective.
Folate-targeted docetaxel-lipid-based-nanosuspensions for active-targeted cancer therapy
TLDR
The results of the in vivo biodistribution study indicate that the better antitumor efficacy of tLNS was attributed to the increased accumulation of the drug in the tumor.
How nanotechnology can enhance docetaxel therapy
TLDR
This review focuses on the research progress in nanoformulations related to docetaxel delivery – such as polymer-based, lipid- based, and lipid-polymer hybrid nanocarriers, as well as inorganic nanoparticles – addressing their structures, characteristics, preparation, physicochemical properties, methods by which drugs are loaded into them, and their in vitro and in vivo efficacies.
Progress of drug-loaded polymeric micelles into clinical studies.
  • H. Cabral, K. Kataoka
  • Biology, Chemistry
    Journal of controlled release : official journal of the Controlled Release Society
  • 2014
...
...